Status:
COMPLETED
Thoracic Epidural Anesthesia Reduces Mortality and Rehospitalization for Patients With Heart Failure With Reduced Ejection Fraction
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University
Conditions:
Heart Failure With Reduced Ejection Fraction
Thoracic Epidural Anesthesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite significant scientific breakthrough in management, patients with heart failure with reduced ejection fraction (HFrEF) remain high morbidity and mortality, with a 5-year survival rate of 25% af...
Eligibility Criteria
Inclusion
- The present study was a retrospective, observational, matched case-control study of 1,840 consecutive inpatients, in New York Heart Association functional class II-IV with a left ventricular ejection fraction (LVEF) ≤40%, who were hospitalized from July 2013 to August 2019.
Exclusion
- Patients were excluded because of insufficient patient information, refusal to participate, or loss to follow-up by telephone. In patients with multiple hospitalizations during the time period, the first hospitalization was utilized in the analysis.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
1840 Patients enrolled
Trial Details
Trial ID
NCT06068166
Start Date
July 1 2013
End Date
August 31 2023
Last Update
March 13 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.